{"rows":[{"id":82,"title":"Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.","authors":"Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J","journal":"Schizophrenia research","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1016/j.schres.2026.03.003","pubmed_id":"41830808","openalex_id":"https://openalex.org/W7135185290","source_url":"https://pubmed.ncbi.nlm.nih.gov/41830808/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:49","bibtex":null,"source_record_id":"PMID:41830808","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41830808/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41830808","source_url":"https://pubmed.ncbi.nlm.nih.gov/41830808/","doi":"10.1016/j.schres.2026.03.003","pmid":"41830808","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":1,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Schizophrenia research","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}